Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

3-Bromophenylalanine

    • Product Name 3-Bromophenylalanine
    • Alias 3-Bromo-DL-phenylalanine
    • Einecs 252-988-8
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    842324

    Cas Number 4560-42-1
    Molecular Formula C9H10BrNO2
    Molecular Weight 244.09 g/mol
    Iupac Name (S)-2-Amino-3-(3-bromophenyl)propanoic acid
    Appearance White to off-white solid
    Melting Point 168-172 °C
    Solubility In Water Slightly soluble
    Purity Typically ≥98%
    Smiles C1=CC(=CC(=C1)Br)CC(C(=O)O)N
    Storage Temperature 2-8 °C

    As an accredited 3-Bromophenylalanine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing
    Shipping
    Storage
    Application of 3-Bromophenylalanine

    Applications of 3-Bromophenylalanine in Industrial Manufacturing

    3-Bromophenylalanine serves as a specialized aromatic amino acid derivative supporting high-value processes in pharmaceutical synthesis, peptide research, and advanced chemical manufacturing. Our production expertise ensures traceable quality and batch reliability for downstream sectors requiring tight compositional control and validated performance in regulated environments. Below we outline established application scenarios backed by industry benchmarks and actual customer implementations.

    1. Peptide Active Pharmaceutical Ingredient (API) Synthesis

    Innovator and generic pharmaceutical manufacturers use 3-bromophenylalanine to incorporate precise halogenated phenylalanine residues in therapeutic peptides targeting oncology and metabolic disorders. Its regulated presence in the peptide chain permits site-specific chemical modification including crosslinking or radiolabeling, boosting candidate diversity for drug discovery and clinical production pipelines. Our facility maintains parallel batch systems and rigorous in-process validation to meet global medicinal requirements.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • United States Pharmacopeia (USP) General Chapter <1207> for Residual Solvents
    • European Pharmacopoeia (Ph. Eur.) General Monographs
    • DMF (Drug Master File) requirement for FDA and EMA submission

    Typical usage ratio

    • 1–8% of total amino acid molar input for peptide chains, adjusted by sequence design and pharmacokinetic requirement

    Downstream process integration

    • Loaded at defined cycles in solid-phase peptide synthesis (SPPS) reactors, following resin swelling and Fmoc deprotection, and prior to cleavage and purification

    Final product types

    • Peptide drug APIs (e.g., labeled antagonists, peptide-drug conjugates)
    • Clinical development lots (preclinical and IND-stage)
    • Specialty oligopeptide building blocks
    • Reference standards for pharmaceutical analysis

    2. Radiopharmaceutical Precursor Manufacturing

    Radioisotope solution providers and contract radiolabeling facilities apply 3-bromophenylalanine as a halogenated aromatic scaffold for synthesizing amino acid tracers used in positron emission tomography (PET). Electrophilic or nucleophilic substitution at the bromine site supports direct labeling, notably for compounds such as 18F-Phe analogs. Our trace metal analysis and isotope compatibility protocols address the strict QMS and cleanroom standards required during radiochemical intermediate preparation.

    Industry compliance standards

    • Good Radiopharmacy Practice (GRPP, EANM Guidelines)
    • 21 CFR Part 212 (Current Good Manufacturing Practice for PET Drugs)
    • ISO 13485 for medical device and radiopharmaceutical production
    • European Pharmacopoeia 2464 (Radiopharmaceutical Preparations)

    Typical usage ratio

    • 0.5–2.5 mmol per batch, determined by targeted radiolabeling molarity and synthetic route (nucleophilic vs. electrophilic substitution)

    Downstream process integration

    • Introduced post-purification as a substrate in isotope labeling reactors, followed by HPLC purification and formulation with sterile excipients

    Final product types

    • PET tracer precursors (e.g., 18F-labeled amino acid analogs)
    • Research-use only (RUO) radiolabeling kits
    • Patient-dosed radiopharmaceuticals (when registered as precursor under cGMP)
    • Quality control and standardization samples for imaging centers

    3. Life Science Research Grade Peptide Synthesis

    Oligopeptide contract research organizations (CROs) and academic core labs rely on 3-bromophenylalanine for custom library synthesis and structure-activity relationship (SAR) investigations. Substitution at the meta-bromo position enables targeted reactivity for fluorescence tagging, affinity probe creation, or mechanistic biochemical studies. Our consistency in chiral purity and residual solvent content supports downstream discovery utility and toxicology batch approval.

    Industry compliance standards

    • ISO 9001 quality management (research reagent supply chain)
    • GLP (Good Laboratory Practices) for nonclinical facility output
    • REACH (Registration, Evaluation, Authorization and Restriction of Chemicals) substance registration
    • NIH/NSF grant procurement guidelines for chemical reagents

    Typical usage ratio

    • Varies between 2–15% of total amino acids for focused libraries, depending on probe design and labeling site frequency

    Downstream process integration

    • Charged to reaction flask during sequence elongation or introduced for fragment condensation in multi-step SPPS or solution-phase protocols

    Final product types

    • Biochemical assay peptides
    • Peptide affinity tags for protein pull-down studies
    • Model compounds for structure-activity relationship analysis
    • Research diagnostic kit components

    4. Advanced Material Synthesis for Bioactive Surfaces

    Specialty materials developers and surface engineering firms adopt 3-bromophenylalanine as a functional monomer for constructing bioactive coatings and immobilized peptide arrays. Covalently attached amino acid analogs enable site-selective crosslinking or further chemical modification, facilitating integration with medical implants, biosensor chips, or tissue engineering scaffolds. Our lot traceability, detailed CoA (including elemental impurities), and batch reservation system ensure reliable supply for scale-up and QC in material science workflows.

    Industry compliance standards

    • ISO 10993 Biocompatibility for medical device raw materials
    • ASTM F2027 Standard Guide for Characterization of Particles
    • RoHS (Restriction of Hazardous Substances Directive, for electronics)
    • GMP Annex 1 guidelines for advanced therapy materials

    Typical usage ratio

    • Typically 0.5–3% by substrate weight during polymer/monomer integration, with adjustments based on desired functional group density and surface coverage

    Downstream process integration

    • Introduced during copolymerization or graft polymer coating, or post-coupling modification of resin surfaces followed by purification and crosslinking

    Final product types

    • Biofunctionalized microarray chips
    • Tissue-engineering scaffold surfaces
    • Peptide-coated implant devices
    • Surface-modified biosensors
    Free Quote

    Competitive 3-Bromophenylalanine prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    3-Bromophenylalanine: An Essential Building Block for Research and Discovery

    Introducing 3-Bromophenylalanine

    3-Bromophenylalanine keeps showing up in the hands of researchers for a reason. This amino acid derivative, modeled off the classic phenylalanine backbone with a bromine atom at the 3-position, sets itself apart when precise molecular tweaks open new windows in peptide synthesis, protein engineering, and tracer experiments. I’ve watched countless colleagues reach for it, not for its novelty, but because it introduces unique chemical handles and electronic properties scientists just can’t get from other options.

    Specifications That Matter in Daily Lab Work

    Whether prepping for a protein labeling run or tuning a peptide for bioactivity, reliable purity makes all the difference. Typical lots of 3-Bromophenylalanine arrive above 98% purity by HPLC. The white crystallized powder form doesn’t just keep storage straightforward—it also shows consistency from batch to batch, so results don’t waver unexpectedly. With a molecular formula of C9H10BrNO2 and a relative molecular mass just over 242 g/mol, calculations stay predictable when scaling synthesis or working out stoichiometry for labeling reactions.

    Solubility always plays a role in experimental planning. 3-Bromophenylalanine dissolves well in polar solvents common in the laboratory, especially dilute bases or acids, so it slips smoothly into most peptide synthesis workflows and chromatographic separations. Storage recommendations usually steer toward cool, dry environments—think desiccators or refrigerators. The relatively stable shelf-life encourages stocking extra without worrying about rapid degradation, though I always prefer freshly opened vials for critical procedures to be sure about quality.

    Pushing Boundaries in Research Applications

    Plenty of folks immediately ask why add bromine to phenylalanine. The answer usually lands in two buckets: as a synthetic handle and for its electronic effects. In the lab, the bromine atom enables diverse transformations. For instance, it’s a popular choice in Suzuki and Buchwald-Hartwig coupling—methods that chemists use every week to link molecular fragments. With 3-bromo substituents, these reactions can introduce fluorescent probes, covalent modulators, or even isotope tags, creating tools for everything from receptor mapping to pharmacokinetics.

    Incorporating 3-Bromophenylalanine into peptide chains by solid-phase synthesis unlocks new possibilities. I recall working on a project screening antimicrobial peptide variants: substitution with 3-bromophenylalanine not only helped track peptides by mass spectrometry, but it also shifted their binding properties, sometimes for the better. The added bromine boosts the peptide’s utility as a probe, and occasionally alters its interaction with biological membranes, enzymes, or receptors.

    Researchers looking at post-translational modifications leverage its chemical handle for site-specific conjugation. In my own work, placing 3-bromophenylalanine at precise sites in a peptide let us attach PEG chains efficiently—a trick that improved solubility and stability during preclinical screens. It also lends itself well to radiolabeling or halogen-exchange reactions, making it invaluable in radioactive tracer development where alternatives are scarce or less effective.

    Setting 3-Bromophenylalanine Apart From Similar Compounds

    Scientific suppliers stock a whole lineup of substituted phenylalanines—fluoro, chloro, iodo—and unmodified types. Each version carves out its own use. What always pulls attention to the bromo version is its balance between reactivity and stability. Compared to iodo analogs, 3-Bromophenylalanine offers a sweeter spot between shelf life and ease of coupling chemistry. Iodobenzenes couple faster but can degrade in storage or during long syntheses. Fluoro and chloro versions, meanwhile, often won’t deliver the electronic push needed for certain transformations, or lack the “handle” size for tracking and modification.

    Phenylalanine itself slips into many reactions, but it brings fewer options for functional modification. 3-Bromophenylalanine doesn’t just work as a plug-in replacement; it redefines what can be built on the backbone. Whether plotting out multi-step syntheses for drug candidates, or engineering nuanced peptide libraries for diagnostics, researchers regularly find that the unique profile of its bromine substituent stands up to both chemical and biological demands.

    Impact on Peptide Synthesis and Protein Engineering

    Peptide therapeutics have become an explosive area in drug discovery. Just looking at the flood of new peptide-based drugs, it’s clear why precise amino acid building blocks matter. 3-Bromophenylalanine helps medicinal chemists create highly tailored molecules with optimized stability and function. In several projects, adding this building block unlocked side-chain crosslinking—resulting in peptides with improved cell permeability, which can mean better oral bioavailability or more selective activity.

    Protein engineers, too, have found clever uses. In systems for site-selective labeling, placing a bromo-phenylalanine at a known position in a recombinant protein lets researchers attach fluorescence tags, affinity labels, or immobilization anchors during downstream analysis. One colleague recounted how swapping tyrosine with 3-Bromophenylalanine in a binding protein allowed attachment of a prodrug, leading to an enzymatic switch that responded to disease cues.

    What differentiates the bromo analog is not just new chemistry, but the chance to probe biology with more precision. By swapping out a “natural” building block for a functionalized one, the lab is able to ask new questions—about folding, targeting, and reactivity—that wouldn’t be possible otherwise. In workflow terms, this means more efficient discovery and validation of lead compounds or labeling strategies.

    Bringing E-E-A-T into Routine Practice

    Experience matters in science. Years of hands-on research in peptide synthesis and protein engineering may teach more about reagent reliability than any catalog. Trust builds when results stay reproducible between batches, and that trust encourages further experimentation. Peers often exchange notes about suppliers whose material actually matches the label spec and delivers expected coupling yields. More than once I’ve seen protocol troubleshooting boil down to confirming the exact substitution pattern or purity of a synthetic amino acid in the chain.

    Transparency about product origin, analytical data, and ideal storage boosts confidence, especially for labs working under regulatory or quality frameworks. Third-party analytical confirmation—like NMR, mass spectrometry, or HPLC spectra—backs up the product’s stated quality. Labs should look for documented evidence detailing chemical purity and absence of key contaminants, as these factors can affect downstream bioactivity, toxicity, or labeling efficiency. I’ve found that providing full characterization up front reduces experimental uncertainty and shortens project timelines—time that’s better spent analyzing results, not patching failed syntheses.

    Supporting Responsible Research and Safety

    Working with halogenated compounds, safety never becomes routine. Like many organic compounds containing bromine, 3-Bromophenylalanine calls for careful handling. Respirable powders always require lab coats, gloves, and a fume hood to prevent unnecessary inhalation or contact. Experienced lab members train newcomers in transfer and weighing techniques to minimize exposure, and I make sure the materials data sheet stays close at hand. Waste disposal follows protocols for halogenated organics to keep both people and the environment safe.

    Environmental stewardship and compliance shape how I choose and use laboratory chemicals. Some regions impose additional regulations on halogenated compounds, so ongoing review of local guidelines makes sure research stays compliant. Storage in sealed, labeled containers limits accidental contamination or misidentification—small steps that prevent big headaches down the line.

    Solutions for Common Challenges in Application

    Smooth integration into peptide synthesis sometimes hits snags—most often with coupling efficiency or side-reactions during chain extension. Years of experience show that double activation using coupling agents—such as HATU or PyBOP—along with in situ base can fend off incomplete reactions. Sometimes a short trial run with small-scale resin saves resources by spotting yield problems before committing to a full synthesis. Careful monitoring by HPLC after each coupling step picks up on problems early.

    Another challenge comes from chromatographic purification. The added bromine atom shifts hydrophobicity and UV absorbance, making method development a critical step. Starting with a steeper gradient or altered wavelength for detection often resolves separation issues. In a peptide library containing multiple unnatural analogs, even minimal retention time shifts can improve resolution and final product characterization.

    Scale-up brings its own lessons. Larger syntheses create more dust and risk, so adopting closed transfer systems and dedicated equipment not only protects staff but limits cross-contamination. Investment in good balances, air extraction, and training pays for itself in reproducible product quality and improved safety records. These practical improvements don’t just secure outcomes for one project—they provide a foundation for future work with similar compounds.

    Real-World Problems and Long-Term Solutions

    Labs across the globe face pressures on both budgets and time. 3-Bromophenylalanine is not the cheapest reagent on the shelf, but its impact justifies the investment when used strategically. In collaborative settings, sharing stocks or purchasing in bulk sometimes reduces per-synthesis cost. Some groups explore in-house synthesis from cheaper starting materials, though that route demands technical know-how, rigorous quality control, and safety measures—tradeoffs that each lab weighs based on resources and expertise.

    Wider adoption argues for proactive training and documentation. Supporting new researchers with tutorials or protocols troubleshooting unnatural amino acid incorporation lifts the overall success rate for both peptides and proteins. Open sharing of protocols through lab websites or workshops accelerates collective learning. Communication with suppliers about batch quality and consistency keeps the supply chain responsive to field needs.

    With ever-growing demands for reproducibility in drug discovery and diagnostics, standardizing procurement and handling protocols for critical reagents like 3-Bromophenylalanine supports robust, credible research. I have seen multinational teams benefit from shared templates for ordering, storage, and waste handling, which keeps everyone on the same page and limits batch-to-batch surprises.

    Future Perspectives for the Field

    Innovation climbs on the backs of reliable tools. As research asks more targeted questions—about protein function, new therapeutics, or diagnostic probes—the need for structurally precise, functionalized amino acids intensifies. 3-Bromophenylalanine consistently shows up in leading-edge studies not because it’s trendy, but because its unique traits solve real-world challenges.

    Collaborations between academic labs, pharmaceutical developers, and reagent suppliers keep raising the quality and accessibility of this building block. New protocols published in peer-reviewed journals and updated supplier information feed into a virtuous cycle: as researchers learn more about what works, they make better choices and design more robust experiments. Open discussion of challenges, setbacks, and solutions helps everyone reach reliable, actionable results.

    Looking ahead, improvements in green chemistry and manufacturing—such as reduced waste halogenation, better recovery methods, and increased recycling—will lower costs and minimize environmental footprint, while keeping product quality high. Widespread adoption of digital tracking for lot verification, storage, and use histories could soon eliminate the headaches of recordkeeping and raw material traceability.

    Why 3-Bromophenylalanine Keeps Earning Its Place

    Every researcher has a few “go-to” reagents that sit at the edge of the bench—a signal of their value in pushing boundaries and troubleshooting unexpected results. 3-Bromophenylalanine stands out in my lab for its reliability, flexibility, and unique chemical potential. It helps uncover answers about how modified amino acids influence protein function, improves the design of therapeutic peptides, and adds new dimensions to labeling and tracking experiments. The choice isn’t about hype, but about utility confirmed through repeated success, day in and day out, in the ferment of real research.

    As experiments become more ambitious and the standards of reproducibility rise, 3-Bromophenylalanine’s role only grows. The backbone of good science is not just clever ideas, but steady, trustworthy materials. After years working in the intersection of chemistry and biology, I’ve come to appreciate how an exceptional tool—like this modified amino acid—can accelerate not just experiments, but scientific careers. Any lab looking to add reliable, versatile, and precise functionality to their peptides or proteins will eventually find its way to this compound, finding new insight and possibility along the journey.